Previous Article | Next Article ![]()
Journal of Virology, July 1999, p. 6171-6176, Vol. 73, No. 7
Department of Molecular Genetics and
Microbiology, Gene Therapy Center, and University of Florida Brain
Institute, College of Medicine, University of Florida, Gainesville,
Florida 32610-0266
Received 28 October 1998/Accepted 9 April 1999
The mobile transgene constructs of most human immunodeficiency
virus (HIV)-based lentivirus vectors currently in use contain viral
long terminal repeats, a 5' untranslated region, gag
sequences, and env sequences that include the
Rev-responsive element (RRE). In this study, we examined the
possibility of deleting HIV splice sites and gag and
env sequences from an HIV type 1 recombinant vector
established in our laboratory as part of our ongoing efforts to improve
this vector system. Mutations in the major splice donor site (SD)
markedly reduced viral RNA expression but had little effect on vector
titer. Deletion of gag or env sequences,
excluding RRE, led to a moderate reduction in vector titer.
Interestingly, deletion of RRE slightly reduced viral RNA expression
but markedly impaired vector function. Combined deletions of RRE,
gag (except for the first 40 nucleotides), env,
and the SD mutation resulted in a twofold increase in cytoplasmic viral
RNA expression and a recovery of vector efficiency to ~50% of the
wild-type level. This increase in cytoplasmic RNA levels is likely to
be due, at least in part, to effects of the TE671 host cells, a human
rhabdomyosarcoma cell line used for vector production in our system, on
the cytoplasmic distribution of spliced and unspliced viral RNA. These
results show that optimal lentivirus vector function can be maintained in the absence of multiple essential viral elements.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Contributions of Viral Splice Sites and
cis-Regulatory Elements to Lentivirus Vector
Function
*
Corresponding author. Mailing address: Rm. R1-252, ARB,
Department of Molecular Genetics and Microbiology, Gene Therapy Center, University of Florida, Gainesville, FL 32610-0266. Phone: (352) 392-3315. Fax: (352) 392-3133. E-mail:
lchang{at}college.med.ufl.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|